Pilot Acute Myeloid Leukaemia Gene Panels (not accredited)

 

The programme is primarily aimed at participants using Next Generation Sequencing (NGS) panels to diagnose and prognosticate Acute Myeloid Leukaemia. Two Acute Myeloid Leukaemia samples will be issued and participants will be expected to test the samples with their in-house panels and report any pathogenic intragenic and/or regulatory element changes such as point mutations, small insertion, deletion and duplications events. Participants will not be requested to report larger changes affecting genome architecture or copy number changes (>50kb). 

 

Pre issue testing of samples for this programme is subcontracted, although the final decision about sample suitability lies with the EQA provider; no other activities in relation to this EQA programme are subcontracted.

 
Example Acute Myeloid Leukaemia Gene Panels Report
To view the annotations on this report, please download the PDF and view in a PDF reader such as Adobe Acrobat.
Example Acute Myeloid Leukaemia Gene Pan[...]
Adobe Acrobat document [682.3 KB]
Print Print | Sitemap

Follow Us Online!
Facebook Twitter LinkedIn Youtube

Disclaimer

Last updated 25th July 2017 © UK NEQAS for Leucocyte Immunophenotyping not to be reproduced in all or part without permission.

This website uses cookies. For more information, please click here.